BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 15, 2008
View Archived Issues
Exelixis Getting $195M Up Front in BMS Cancer Collaboration
Exelixis signed a major deal with Bristol-Myers Squibb Co., in which the drugmaker would pay a hefty $195 million up front for rights to cancer programs developed by Exelixis. (BioWorld Today)
Read More
Daschle to Lead HHS, White House Health Reform Office
Read More
Momenta's Offering Adds $25M as FOBs Gain Momentum
Read More
BioPartnering: Learn How to Make the Right Moves
Read More
Vivus' Avanafil Starts Pivotal Testing in Erectile Dysfunction
Read More
Disappointing Memory Data Send Lexicon Shares Sliding
Read More
Other News To Note
Read More
Clinic Roundup
Read More
CTRC-AACR Roundup
Read More